Cath lab

2022 HospeTrack Hospital Intelligence Insights for Bahrain - Featuring Fresenius Medical Care, Drager, Philips Healthcare and Siemens Healthineers Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, December 19, 2022
Health, Other Health, Universe, Hospital, Total, Dräger (company), Public, MRI, Degenerative disease, SPECT, Worksheet, Fresenius Medical Care, GPS, Siemens Healthineers, ORS, Growth, Size, COVID-19, CT, Kingdom, ICU, Incubator, Room, Non-communicable disease, Private sector, Teaching hospital, Philips, GE Healthcare, Critical care, Canon Medical Systems Corporation, Type, Hitachi, Cath lab, PET, Investment, Data, Physician, Microsoft Excel, Cardiology, Research, Google Images, Bed, GCC, Cryptocurrency, Healthcare, Health insurance, Medical imaging, Medical device, Toshiba

Key medical device companies featured in the dataset include: Fresenius Medical Care, Drager, Philips Healthcare, Siemens Healthineers, GE Healthcare, Toshiba (Canon Medical Systems), Hitachi, Mindray.

Key Points: 
  • Key medical device companies featured in the dataset include: Fresenius Medical Care, Drager, Philips Healthcare, Siemens Healthineers, GE Healthcare, Toshiba (Canon Medical Systems), Hitachi, Mindray.
  • HospeTrack Hospital Intelligence for Bahrain, Guidance & Hospital Segmentation
    Provides brief methodology of research along with extensive detail around total coverage of hospitals in Bahrain, by type of hospital.
  • HospeTrack Hospital Intelligence for Bahrain, Insight Summary
    3.4 IB Penetration Summary for Bahrain by Care Level of Hospital, 2022
    4.
  • HospeTrack Hospital Intelligence for Bahrain, IB Base File
    Provides the raw data for all installed base equipment by account in Bahrain.

HospeTrack Hospital Intelligence for Myanmar 2022: Opportunities to be Found in Public & Private Secondary Care Facilities - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 24, 2022
Hospitals, Health Technology, Health, Hospital, ICU, Jaundice, Light, Sepsis, NICU, Joint Commission on Allied Health Personnel in Ophthalmology, Bed, Life expectancy, PET, Incubator, MRI, India and the World Bank, SPECT, Private, Cath lab, Woman, World Bank, GDP, Infant, Physician, Asphyxia, Specialist, Ministry, ORS, Education, Degenerative disease, CT, Health, Risk, ASEAN, Healthcare Facilities Accreditation Program, Chin, Medicine, Ultrasound, Mammography, Dialysis

With a fragile economy, growth opportunities for medical devices remain restricted in Myanmar.

Key Points: 
  • With a fragile economy, growth opportunities for medical devices remain restricted in Myanmar.
  • As of 2021-22, Myanmar has 1,063 healthcare facilities, with 948 public hospitals, 106 private hospitals, and 9 military hospitals.
  • According to this HospeTrack Hospital Intelligence for Myanmar, market opportunities for the next 5-10 years lie in secondary care public and private facilities for neonatal care equipment.
  • Assess and differentiate based on size of hospital - General hospital, Station hospital,100-bedded, 50-bedded, 25-bedded, Specialist hospital, Private hospital and Imaging centers
    1,063 hospitals and Imaging centers in Myanmar listed by city, region, latitude and longitude and Zip Code

Australia HospeTrack Hospital Intelligence Report 2022: Upcoming Developments in Cancer Care Infrastructure to Drive Demand in Australia's Medical Device Industry - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 23, 2022
Hospitals, Health, Oncology, Prevalence, ICU, Medical Research Future Fund, Government, PET/CT, DEXA, Bed, Molecular imaging, LINAC, Life expectancy, PET, Incubator, MRI, Cancer, SPECT, Medicare, Cath lab, Research, Nuclear medicine, Mental health, Diabetes, ORS, Conditional sentence, CT, Diagnosis, University, Incidence, Medical imaging, Health insurance, Ultrasound, Mammography, Dialysis

Upcoming developments in cancer care infrastructure to drive demand in Australian medical device industry.

Key Points: 
  • Upcoming developments in cancer care infrastructure to drive demand in Australian medical device industry.
  • As of 2021-22, Australia has 655 public healthcare facilities and 1,317 private facilities including imaging centers.
  • Australia has the highest number of cancer cases in the world, with an estimated 150,000 cases of cancer diagnosed each year.
  • According to this HospeTrack Hospital Intelligence for Australia, nuclear medicine and molecular imaging market is likely to present pockets of growth opportunities primarily related to the increasing prevalence of cancer.

HospeTrack Hospital Intelligence for Denmark: A Vision of Modernizing Hospital Infrastructure for a Sustainable Future - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 17, 2022
Hospitals, Health Technology, Health, Hospital, EUR, PET-CT, Health information management, Information technology, SPECT, Cath lab, Data, EMR, Medicine, Database, Renewable energy, Medical imaging

Denmark's healthcare market to be driven by the country's vision of modernizing hospital infrastructure for a sustainable future.

Key Points: 
  • Denmark's healthcare market to be driven by the country's vision of modernizing hospital infrastructure for a sustainable future.
  • As of 2021-22, Denmark has about 56 public and 58 private healthcare facilities including imaging centers spread throughout the five regions.
  • This HospeTrack is the largest database of hospital level medical equipment installed base data, currently available on the market.
  • The Denmark Total Hospital & Medical IB Mapping report was updated in 2022 and includes over 114 hospitals and imaging centers from the country with their health infrastructure detailed out.

Germany Hospital Intelligence Report 2022: Details on Total Beds, ICU Beds, ORs, Ventilators, Incubators, Imaging Equipment and Other Medical Equipment - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 25, 2022
Medical Devices, Health, Hospitals, Surgery, Radiology, Cardiology, ORS, ICU, Government, Health, Catheter, Efficiency, Growth, Bed, Public sector, SPECT, Hospital, Data, Cath lab, Mortality, MRI, CT, PET, Nursing, Myocardial infarction, Life expectancy, Degenerative disease, Incubator, Patient, Medical imaging, Dialysis, Mammography, Ultrasound

The country has the highest number of doctors and nurses across Europe and continues to expand its healthcare resources.

Key Points: 
  • The country has the highest number of doctors and nurses across Europe and continues to expand its healthcare resources.
  • With healthcare expenditures majorly borne by the government, Germany has one of the more efficient healthcare systems in the region.
  • According to this HospeTrack Hospital Intelligence for Germany, medical device market opportunities are significant in the secondary care segment for cardiovascular imaging equipment.
  • Patients in Germany continue to seek emergency care for treatable cardiac procedures that can be done on an outpatient basis.

YorLabs Appoints Gregory D. Casciaro to Board of Directors

Retrieved on: 
Tuesday, October 25, 2022
Business administration, Workflow, Marquette University, Algorithm, Patient, Degenerative disease, Cath lab, Technology, Industry, Board, CEO, Health, Casciaro, Board of directors, Johnson & Johnson Vision, Record, Solution, Cardinal Health, Pharmaceutical industry, Medical imaging, Electrophysiology

PORTLAND, Ore., Oct. 25, 2022 /PRNewswire-PRWeb/ -- YorLabs, a developer of cutting-edge intracardiac image guided therapy solutions, today announced the appointment of Gregory "Greg" D. Casciaro to the company's Board of Directors. Casciaro has 40 years of medical device experience and has held leadership roles in both public and private companies.

Key Points: 
  • PORTLAND, Ore., Oct. 25, 2022 /PRNewswire-PRWeb/ -- YorLabs, a developer of cutting-edge intracardiac image guided therapy solutions, today announced the appointment of Gregory "Greg" D. Casciaro to the company's Board of Directors.
  • "We are pleased to welcome Greg to the YorLabs leadership team," said Glen McLaughlin, president and CEO, YorLabs.
  • "I joined the Yorlabs board, because of the high quality team Glen has assembled," said Casciaro.
  • "Greg is well qualified to serve on our board of directors," said Anshumali Roy, founder and chief technology officer for YorLabs.

HospeTrack Hospital Intelligence for United Kingdom: Analysis on Hospital Level Equipment Currently Available - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 20, 2022
Health, Hospitals, Adoption, NHS, ORS, ICU, Government, Bed, SPECT, Hospital, Data, Cath lab, Investment, MRI, Artificial intelligence, CT, Budget, Google Images, Medicine, Telehealth, PET, Database, Incubator, App Store (iOS/iPadOS), Medical imaging

The "HospeTrack Hospital Intelligence for United Kingdom" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "HospeTrack Hospital Intelligence for United Kingdom" report has been added to ResearchAndMarkets.com's offering.
  • As of 2021-22, UK has about 1,055 public and 278 private healthcare facilities spread throughout Great Britain and Northern Ireland.
  • According to this HospeTrack Hospital Intelligence for UK, one of the major opportunities for the medical device manufacturers includes construction and expansion of 40 major hospitals across England by 2030.
  • This HospeTrack is the largest database of hospital level medical equipment installed base data, currently available on the market.

Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices

Retrieved on: 
Friday, October 7, 2022
Adoption, Physician, U.S. Securities and Exchange Commission, SEC, Achievement, Growth, Acceleration, Family, NASDAQ, Patient, Research, Federal, Security (finance), Cath lab, Collection, Nasdaq, Technology, Private Securities Litigation Reform Act, Food, Goal, Company, Acquisition, Food and Drug Administration, CEO, Ecosystem, PTCA, GLOBE, Expansion, Maintenance, Intellectual property, Forward-looking statement, Robotics, Vision Guided Robotic Systems, Failure, CTO, FDA, COVID-19, Medical device, 3D printing

HINGHAM, Mass., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced today, as a continuation of its recent regulatory and future commercialization activities, together with its strategic mission to enable accessibility to multiple endovascular procedures globally, that it has acquired the assets of privately-held Nitiloop Ltd. The acquisition includes the NovaCross™ family of Microcatheters (NovaCross CTO, NovaCross Xtreme and NovaCross BTK), a U.S. Food and Drug Administration (FDA) cleared family of medical devices intended to facilitate the intraluminal placement of conventional and steerable guidewires beyond stenotic lesions, including chronic total occlusions (CTO), prior to PTCA or stent intervention.

Key Points: 
  • The NovaCross Microcatheter family, as a standalone device or when potentially integrated with the Companys One & Done technology, is expected to create a collection of procedure related kits that are customized for the LIBERTY Robotic System.
  • The LIBERTY Robotic System is the first-ever disposable endovascular robotic system with remote operation capabilities and small footprint designed to reduce the requirement of capital investment and Cath Lab space.
  • The Company believes the achievement of the LIBERTY Robotic System ecosystem will allow Microbot Medical to advance the adoption of robotics in the endovascular space, globally.
  • Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Global Drug Eluting Balloon Market Report 2022: Rising Occurrence of Peripheral and Coronary Artery Diseases Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 21, 2022
Pharmaceutical, Health, Medical Devices, Observation, Porter's five forces analysis, COVID-19, Hospital, Cath lab, Risk, Geography, Growth, Ambulatory Surgery Center Association, Ansoff Matrix, Industry, Market development, Journal of Global Drug Policy and Practice, USD, Investment, SWOT, CAGR, Pharmaceutical industry, Retail, Risk management, Medical device, Technology

The Global Drug Eluting Balloon Market is segmented based on Type, Technology, End-user, and Geography.

Key Points: 
  • The Global Drug Eluting Balloon Market is segmented based on Type, Technology, End-user, and Geography.
  • By Type, the market is classified into Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon.
  • The report presents a detailed Ansoff matrix analysis for the Global Drug Eluting Balloon Market.
  • The report offers a comprehensive evaluation of the Global Drug Eluting Balloon Market.

YorLabs Completes First Phase of Executive Management Team Appointments

Retrieved on: 
Tuesday, July 12, 2022
Technology, Algorithm, Goal, Transducer, Environment, EP, McLaughlin, Board, IC, Cath, Cath lab, Workflow, Global Partnership for Education, Glen McLaughlin, Priscilla, Electrophysiology, Solution, Management

PORTLAND, Ore.,  July 12, 2022  /PRNewswire-PRWeb/ -- YorLabs, a developer of cutting-edge intracardiac image guided therapy solutions, announced it has completed the first phase of appointing the company's executive management team to lead its developmental and commercialization endeavors. The company recently appointed William "Bill" Starling as Chairman of the Board; Glen McLaughlin President and Chief Executive Officer; Nikki Troiano Gainey Chief Commercialization Officer, Priscilla "PJ" Ryland Senior Vice President of Global Partnerships; and Tim Marcotte Chief Financial Officer.

Key Points: 
  • PORTLAND, Ore., July 12, 2022 /PRNewswire-PRWeb/ -- YorLabs, a developer of cutting-edge intracardiac image guided therapy solutions, announced it has completed the first phase of appointing the company's executive management team to lead its developmental and commercialization endeavors.
  • YorLabs is designing its solution to provide automatic upgrades to maintain cutting-edge technology throughout the lifecycle of the platform.
  • We are pleased to have such a strong executive team to lead these efforts."
  • The YorLabs solution is designed to be an intuitive platform while eliminating capital outlays and significantly enhancing workflow.